CrystalGenomics Inc
KOSDAQ:083790
CrystalGenomics Inc
Inventory
CrystalGenomics Inc
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
CrystalGenomics Inc
KOSDAQ:083790
|
Inventory
₩11.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
40%
|
|
|
Celltrion Inc
KRX:068270
|
Inventory
₩2.7T
|
CAGR 3-Years
62%
|
CAGR 5-Years
47%
|
CAGR 10-Years
27%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Inventory
₩455.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Inventory
₩6.7B
|
CAGR 3-Years
49%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CrystalGenomics Inc
Glance View
CrystalGenomics, Inc. engages in the discovery and development of novel therapeutics. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2006-01-06. The firm operates its business through four segments. The Drug Substance Manufacturing segment manufactures and sells drug substances such as anti-inflammatory analgesics, antispasmodics, and asthma treatments. The Finished Drug Manufacturing segment produces and supplies finished drugs such as cephalosporin antibiotics. The Pharmaceutical Research and Development segment is engaged in the provision of clinical trial analysis and technical services, and sales of new drugs. The company also engages in real estate rental business. The Other segment is engaged in the manufacture and sale of hot pats and other household goods.
See Also
What is CrystalGenomics Inc's Inventory?
Inventory
11.8B
KRW
Based on the financial report for Sep 30, 2025, CrystalGenomics Inc's Inventory amounts to 11.8B KRW.
What is CrystalGenomics Inc's Inventory growth rate?
Inventory CAGR 10Y
40%
Over the last year, the Inventory growth was 373%. The average annual Inventory growth rates for CrystalGenomics Inc have been -1% over the past three years , -5% over the past five years , and 40% over the past ten years .
